+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ropivacaine"

From
Local Anesthesia Drugs - Global Strategic Business Report - Product Thumbnail Image

Local Anesthesia Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 94 Pages
  • Global
From
Local Anesthesia Drugs Market Report 2025 - Product Thumbnail Image

Local Anesthesia Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
  • 16 Results (Page 1 of 1)
Loading Indicator

Ropivacaine is an anesthetic drug used for local and regional anesthesia. It is a local anesthetic of the amide type and is used for infiltration, nerve block, and epidural anesthesia. It is a long-acting anesthetic with a rapid onset and a duration of action of up to three hours. Ropivacaine is used in a variety of medical procedures, including orthopedic, dental, and obstetric procedures. It is also used in the treatment of chronic pain. Ropivacaine is available in a variety of formulations, including injectable solutions, topical solutions, and transdermal patches. It is also available in combination with other drugs, such as epinephrine and bupivacaine. The safety and efficacy of ropivacaine have been established in clinical trials. The market for ropivacaine is highly competitive, with several companies offering products. Some of the major players in the market include Hospira, Inc., Baxter International, Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., and Fresenius Kabi AG. Show Less Read more